These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 29479081)

  • 1. Hypertension: Role of C3aR and C5aR in T
    Carney EF
    Nat Rev Nephrol; 2018 Apr; 14(4):214. PubMed ID: 29479081
    [No Abstract]   [Full Text] [Related]  

  • 2. Deficiency of Complement C3a and C5a Receptors Prevents Angiotensin II-Induced Hypertension via Regulatory T Cells.
    Chen XH; Ruan CC; Ge Q; Ma Y; Xu JZ; Zhang ZB; Lin JR; Chen DR; Zhu DL; Gao PJ
    Circ Res; 2018 Mar; 122(7):970-983. PubMed ID: 29437833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
    Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
    FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: Receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells.
    van der Touw W; Cravedi P; Kwan WH; Paz-Artal E; Merad M; Heeger PS
    J Immunol; 2013 Jun; 190(12):5921-5. PubMed ID: 23690475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
    Drouin SM; Kildsgaard J; Haviland J; Zabner J; Jia HP; McCray PB; Tack BF; Wetsel RA
    J Immunol; 2001 Feb; 166(3):2025-32. PubMed ID: 11160252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementing T Regulatory Cells to Combat Hypertension.
    Mathis KW
    Circ Res; 2018 Mar; 122(7):911-912. PubMed ID: 29599271
    [No Abstract]   [Full Text] [Related]  

  • 7. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
    Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
    Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
    Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
    J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse.
    Van Beek J; Bernaudin M; Petit E; Gasque P; Nouvelot A; MacKenzie ET; Fontaine M
    Exp Neurol; 2000 Jan; 161(1):373-82. PubMed ID: 10683302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of the anaphylatoxin receptors, complement anaphylatoxin 3a receptor and complement anaphylatoxin 5a receptor, in the nasal mucosa of patients with mild and severe persistent allergic rhinitis.
    Jun SW; Kim TH; Lee HM; Lee SH; Kim WJ; Park SJ; Kim YS; Lee SH
    J Allergy Clin Immunol; 2008 Jul; 122(1):119-25. PubMed ID: 18538384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression.
    Sayah S; Ischenko AM; Zhakhov A; Bonnard AS; Fontaine M
    J Neurochem; 1999 Jun; 72(6):2426-36. PubMed ID: 10349852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies.
    Zwirner J; Götze O; Begemann G; Kapp A; Kirchhoff K; Werfel T
    Immunology; 1999 May; 97(1):166-72. PubMed ID: 10447728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skin.
    Kirchhoff K; Weinmann O; Zwirner J; Begemann G; Götze O; Kapp A; Werfel T
    Immunology; 2001 Jun; 103(2):210-7. PubMed ID: 11412308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement gene expression is regulated by pro-inflammatory cytokines and the anaphylatoxin C3a in human tenocytes.
    Busch C; Girke G; Kohl B; Stoll C; Lemke M; Krasnici S; Ertel W; Silawal S; John T; Schulze-Tanzil G
    Mol Immunol; 2013 Apr; 53(4):363-73. PubMed ID: 23070120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement Split Products C3a/C5a and Receptors: Are They Regulated by Circulating Angiotensin II Type 1 Receptor Autoantibody in Severe Preeclampsia?
    Ye Y; Kong Y; Zhang Y
    Gynecol Obstet Invest; 2016; 81(1):28-33. PubMed ID: 26485247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement 5a receptor mediates angiotensin II-induced cardiac inflammation and remodeling.
    Zhang C; Li Y; Wang C; Wu Y; Cui W; Miwa T; Sato S; Li H; Song WC; Du J
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1240-8. PubMed ID: 24743429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of rat C3a receptor: differential expression of rat C3a and C5a receptors by LPS stimulation.
    Fukuoka Y; Ember JA; Hugli TE
    Biochem Biophys Res Commun; 1998 Jan; 242(3):663-8. PubMed ID: 9464274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
    Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
    J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling through C5aR is not involved in basal neurogenesis.
    Bogestål YR; Barnum SR; Smith PL; Mattisson V; Pekny M; Pekna M
    J Neurosci Res; 2007 Oct; 85(13):2892-7. PubMed ID: 17551982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation.
    Baelder R; Fuchs B; Bautsch W; Zwirner J; Köhl J; Hoymann HG; Glaab T; Erpenbeck V; Krug N; Braun A
    J Immunol; 2005 Jan; 174(2):783-9. PubMed ID: 15634899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.